Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.

@article{Trovik2013HormoneRL,
  title={Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.},
  author={Jone Trovik and Elisabeth Wik and Henrica M. J. Werner and Camilla Krakstad and Harald Helland and Ingrid Vandenput and Tormund S. Njolstad and Ingunn M. Stefansson and Janusz Marcickiewicz and Solveig Tingulstad and Anne Cathrine Staff and Fr{\'e}d{\'e}ric Amant and Lars A. Akslen and Helga Birgitte Salvesen},
  journal={European journal of cancer},
  year={2013},
  volume={49 16},
  pages={
          3431-41
        }
}
BACKGROUND Preoperative histologic examination of tumour tissue is essential when deciding if endometrial cancer surgery should include lymph node sampling. We wanted to investigate if biomarkers could improve prediction of lymph node metastasis and outcome. PATIENTS AND METHODS Curettage specimens from 832 endometrial carcinoma patients prospectively recruited from 10 centres in the MoMaTEC trial (Molecular Markers in Treatment of Endometrial Cancer) were investigated for hormone receptor… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 52 CITATIONS, ESTIMATED 49% COVERAGE

Management of Endometrial Cancer

VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group

  • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • 2019

FILTER CITATIONS BY YEAR

2013
2020

CITATION STATISTICS

  • 5 Highly Influenced Citations

  • Averaged 10 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Endometrial cancer. Lancet 2005;366(9484):491–505

F Amant, P Moerman, +3 authors I. Vergote
  • J. Trovik et al. / European Journal of Cancer
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2013
VIEW 1 EXCERPT

Influence of gynecologic oncologists on the survival of patients with endometrial cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
VIEW 1 EXCERPT

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2011
VIEW 2 EXCERPTS